| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Takeda Pharmaceutical Company Limited (NYSE: TAK)
TAK Technical Analysis
5
| As on 14th Jan 2025 TAK STOCK Price closed @ 13.04 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 14.27 & Strong Sell for SHORT-TERM with Stoploss of 15.42 we also expect STOCK to react on Following IMPORTANT LEVELS. |
TAKSTOCK Price
| Open | 13.03 | Change | Price | % |
| High | 13.10 | 1 Day | 0.05 | 0.38 |
| Low | 13.00 | 1 Week | -0.21 | -1.58 |
| Close | 13.04 | 1 Month | -0.53 | -3.91 |
| Volume | 1694206 | 1 Year | -2.22 | -14.55 |
| 52 Week High 16.32 | 52 Week Low 12.60 | ||||
NYSE USA Most Active Stocks
| FSR | 0.02 | 0.00% |
| DDR | 15.44 | -4.46% |
| TWTR | 53.70 | 0.66% |
| SWN | 7.11 | -0.56% |
| BACA-U | 302.00 | 0.67% |
| FUBO | 3.81 | -14.38% |
| PLTR | 65.91 | 1.43% |
| BBD | 1.93 | 2.12% |
| RPAI | 13.15 | -3.17% |
| LTHM | 16.51 | -8.53% |
NYSE USA Top Gainers Stocks
NYSE USA Top Losers Stocks
| TAK Daily Charts |
TAK Intraday Charts |
Whats New @ Bazaartrend |
TAK Free Analysis |
|
|
TAK Important Levels Intraday
| RESISTANCE | 13.23 |
| RESISTANCE | 13.17 |
| RESISTANCE | 13.13 |
| RESISTANCE | 13.09 |
| SUPPORT | 12.99 |
| SUPPORT | 12.95 |
| SUPPORT | 12.91 |
| SUPPORT | 12.85 |
TAK Forecast January 2025
| 4th UP Forecast | 15.83 |
| 3rd UP Forecast | 14.94 |
| 2nd UP Forecast | 14.38 |
| 1st UP Forecast | 13.83 |
| 1st DOWN Forecast | 12.25 |
| 2nd DOWN Forecast | 11.7 |
| 3rd DOWN Forecast | 11.14 |
| 4th DOWN Forecast | 10.25 |
TAK Weekly Forecast
| 4th UP Forecast | 13.85 |
| 3rd UP Forecast | 13.59 |
| 2nd UP Forecast | 13.43 |
| 1st UP Forecast | 13.27 |
| 1st DOWN Forecast | 12.81 |
| 2nd DOWN Forecast | 12.65 |
| 3rd DOWN Forecast | 12.49 |
| 4th DOWN Forecast | 12.23 |
TAK Forecast2025
| 4th UP Forecast | 20.4 |
| 3rd UP Forecast | 18.04 |
| 2nd UP Forecast | 16.58 |
| 1st UP Forecast | 15.12 |
| 1st DOWN Forecast | 10.96 |
| 2nd DOWN Forecast | 9.5 |
| 3rd DOWN Forecast | 8.04 |
| 4th DOWN Forecast | 5.68 |
Takeda Pharmaceutical Company Limited ( NYSE USA Symbol : TAK )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
TAK Business Profile
Takeda Pharmaceutical Company Limited engages in the research, development, manufacturing, marketing, and out-licensing of pharmaceutical products worldwide. It offers pharmaceutical products in the areas of gastroenterology; oncology; neuroscience; and rare diseases, such as rare metabolic and hematology, and heredity angioedema, as well as plasma-derived therapies and vaccines. The company provides its products under the Entyvio, Gattex/Revestive, Alofisel, Natpara, Adynovate/Adynovi, Takhzyro, Elaprase, Vpriv, Gammagard Liquid/Kiovig, Hyqvia, Cuvitru, Albumin/Flexbumin, Ninlaro, and Alunbrig brands. Takeda Pharmaceutical Company has licensing agreements with Denali Therapeutics and Wave Life Sciences Ltd; collaboration agreements with Neurocrine Biosciences, Inc. and Rani Therapeutics LLC; license and research agreements with The University of Texas MD Anderson Cancer Center, Poseida Therapeutics, Inc., and Arrowhead Pharmaceuticals Inc.; research collaboration agreements with Arrowhead Pharmaceuticals Inc. and Ovid Therapeutics Inc.; and collaboration with Evox Therapeutics Ltd., as well as a licensing agreement with ProThera Biologics Inc. It also has strategic alliances with Egle Therapeutics SAS; Evotec SE; Neurocrine Biosciences, Inc.; Carmine Therapeutics; HemoShear Therapeutics, LLC; KSQ Therapeutics; and Anima Biotech. Takeda Pharmaceutical Company Limited was founded in 1781 and is headquartered in Tokyo, Japan. Address: 1-1, Nihonbashi-Honcho 2-chome, Tokyo, Japan, 103-8668
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service